Effects of PI3K inhibitor LY294002 on the differentiation of mouse preadipocytes and the expression of C/EBPα and PPARγ
GAO Jin-Zhi, ZHENG Rui-Dan, WANG Cheng-Bin, YING Yan-Qin, LUO Xiao-Ping
Department of Pediatrics, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. xpluo@tjh.tjmu.edu.cn
Abstract:OBJECTIVE: This study examined the effects of PI3K inhibitor LY294002 on the differentiation of mouse preadipocytes and the expression of CCAAT enhancer binding protein α (C/EBPα) and peroxisome proliferation activated receptor γ (PPARγ), in order to study the possible roles of insulin receptor substrate (IRSs)/PI3K signal pathway in the differentiation of preadipocytes. METHODS: The mouse 3T3-L1 cells were cultured normally and divided into experimental and control groups. 3T3-L1 cells in the experimental group were treated with PI3K inhibitor LY294002 (25 μmol/L) and those in the control group were treated with DMSO culture medium. 3-isobutyl-1-methylxanthine (IBMX) (0.5 mmol/L), dexamethasone (10-6 mol/L) and insulin (5 μg/mL) were used to induce the differentiation of 3T3-L1 preadipocytes in both groups. Before culture, and 2, 4 and 8 days after culture, the cells were collected to detect the expression of C/EBPα and PPARγ by real-time PCR and Western blot assays. The lipid droplets of 3T3-L1 preadipocytes were observed by oil-red O staining. RESULTS: PI3K inhibitor LY294002 did not affect the expression of C/EBPα and PPARγ in un-induced 3T3-L1 preadipocytes (P>0.05), but decreased the expression of C/EBPα and PPARγ during the in vitro induced differentiation of 3T3-L1 preadipocytes compared with the control group (P<0.05 or 0.01). The lipid droplets count was greatly reduced by LY294002. CONCLUSIONS: PI3K inhibitor LY294002 can inhibit the differentiation of mouse 3T3-LI preadipocytes and the expression of C/EBPα and PPARγ in the differentiation of 3T3-LI preadipoeytes, suggesting that IRSs/PI3K signal pathway may play an important role in the differentiation of 3T3-L1 preadipocytes by regulating the expression of C/EBPα and PPARγ.
GAO Jin-Zhi,ZHENG Rui-Dan,WANG Cheng-Bin et al. Effects of PI3K inhibitor LY294002 on the differentiation of mouse preadipocytes and the expression of C/EBPα and PPARγ[J]. CJCP, 2011, 13(10): 823-826.
[2]Achike FI, To NH, Wang H, Kwan CY. Obesity, metabolic syndrome, adipocytes and vascular function: A holistic viewpoint[J]. Clin Exp Pharmacol Physiol, 2011, 38(1): 1-10.
[3]Tseng YH, Butte AJ, Kokkotou E, Yechoor VK, Taniquchi CM, Kriauciunas KM, et al. Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and nectin[J]. Nat Cell Biol, 2005, 7(6): 601-611.
[4]Rosen ED, Hsu CH, Wang X, Sakai S, Freeman MW, Gonzalez FJ, et al. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway[J]. Genes Dev, 2002, 16(1): 22-26.
[5]Ros Pérez M, Medina-Gómez G. Obesity, adipogenesis and insulin resistance [J]. Endocrinol Nutr, 2011, 58(7): 360-369.
[6]Hayashi T, Nozaki Y, Nishizuka M, Ikawa M, Osada S, Imagawa M. Factor for adipocyte differentiation 158 gene disruption prevents the body weight gain and insulin resistance induced by a high-fat diet[J]. Biol Pharm Bull, 2011, 34(8): 1257-1263.
[7]Rosen ED, MacDougald OA. Adipocyte differentiation from the inside out[J]. Nat Rev Mol Cell Biol, 2006, 7(12): 885-896.